Drug intelligence / Profile preview

Kexinkang

Development stage: Unknown
Lead developer: Jingfukang Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Kexinkang (咳欣康片) is a traditional Chinese medicine (TCM) product developed and manufactured by Chengde JingFuKang Pharmaceutical Group. It is formulated as an oral tablet primarily indicated for the relief of cough and associated respiratory symptoms. As a TCM formulation, its therapeutic effects are derived from a combination of herbal ingredients intended to harmonize respiratory function and alleviate irritation. The product is currently approved and marketed in China as part of Chengde JingFuKang's portfolio of common pharmaceuticals.

Brand names: Kexinkang咳欣康
Other names: Kexinkang TabletsKexinkang Pian咳欣康片

Beyond the preview

Go deeper on Kexinkang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kexinkang.

Explore the full profile